Key result
Leadless pacemaker resolves symptoms without reinfection in a patient with recurrent pacemaker pocket infections.
Why the study?
Cardiac implantable electronic device infections pose a major clinical challenge, particularly in elderly patients with multiple comorbidities.
Case Report (n=1)
Leadless pacemakers offer a safe and effective alternative for patients with recurrent transvenous pacemaker infections, eliminating the need for subcutaneous pockets and transvenous leads.
Answers are grounded in this paper and cite their sources.
May support leadless pacemakers in recurrent infections; hypothesis-generating and requires prospective confirmation.
Cardiac implantable electronic device (CIED) infections pose a major challenge, especially in elderly patients with multiple comorbidities. We describe a 73-year-old woman with hypertension, bronchial asthma, and dyslipidemia who developed recurrent pacemaker site infections following dual-chamber permanent pacemaker implantation. Despite wound debridement and device relocation via the right internal jugular vein, she experienced reinfection and intermittent complete heart block. Coronary angiography revealed normal coronaries. Given her high risk and repeated device-related complications, a leadless pacemaker was implanted via the femoral approach. The procedure was uneventful, and she was discharged in stable condition with satisfactory pacing parameters. Leadless pacemakers, by eliminating transvenous leads and subcutaneous pockets, substantially reduce infection risk and reintervention rates. This case underscores the importance of individualized management and highlights leadless pacing as a safe, effective alternative in patients with recurrent CIED infections, offering improved outcomes and reduced morbidity in high-risk populations.
No takes yet. Share an insight, caveat, or question.
Ranjith et al. (2026) conducted a case report in Elderly female patient (age 73) with symptomatic intermittent complete heart block and recurrent pacemaker pocket infections, with comorbidities including hypertension, bronchial asthma, and dyslipidemia (n=1). Leadless pacemaker implantation (Micra AV2 MC2AVR1, Medtronic) vs. Dual-chamber transvenous permanent pacemaker (prior) was evaluated on Successful leadless pacemaker implantation with no periprocedural complications and absence of recurrent device infection at 3 months, stable pacing parameters, and symptom resolution. Leadless pacemaker implantation was successful without complications and prevented reinfection with stable pacing parameters and symptom resolution at 3 months in an elderly patient with recurrent pacemaker pocket infections.
Synapse has enriched 10 related papers. Consider them for comparative context: